← 返回

树突状细胞亚群及其对癌症免疫治疗的意义

英文原题:Dendritic cell subsets and implications for cancer immunotherapy.

查看英文原题

Dendritic cell subsets and implications for cancer immunotherapy.

PubMed 2024/06/05(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

树突状细胞(DC)在有效抗肿瘤T细胞应答的协调中发挥核心作用。然而,其功能行为具有环境依赖性。DC类型、转录程序、定位、瘤内因子和炎症微环境均会影响DC对肿瘤免疫的促进或抑制作用。以下综述介绍了DC功能的重要方面,以及亚群和表型如何影响DC与肿瘤微环境中其他因素的相互作用。综述还将讨论当前癌症治疗如何依赖DC功能,并概述免疫治疗能够以多种方式更直接地利用DC来实现抗肿瘤细胞毒性。

展开英文摘要原文

Dendritic cells (DCs) play a central role in the orchestration of effective T cell responses against tumors.

However, their functional behavior is context-dependent. DC type, transcriptional program, location, intratumoral factors, and inflammatory milieu all impact DCs with regard to promoting or inhibiting tumor immunity.

The following review introduces important facets of DC function, and how subset and phenotype can affect the interplay of DCs with other factors in the tumor microenvironment. It will also discuss how current cancer treatment relies on DC function, and survey the myriad ways with which immune therapy can more directly harness DCs to enact antitumor cytotoxicity.

论文信息

作者
Chen MY、Zhang F、Goedegebuure SP、Gillanders WE
单位
Department of Surgery, Washington University School of Medicine, St. Louis, MO, United States.United States
文献类型
综述 · 美国 NIH 资助研究 · 非美国政府资助研究
期刊
Frontiers in immunology2024
原文标识
PubMed 38903502 · DOI 10.3389/fimmu.2024.1393451